Cite
HARVARD Citation
Tolcher, A. et al. (n.d.). 161P A phase Ib study to evaluate IK-007 in combination with pembrolizumab (pembro) in patients with advanced microsatellite stable (MSS) colorectal cancer (CRC). Immuno-oncology technology. p. . [Online].